Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / COMMON-STOCK
-
Shares outstanding
-
7,227,333
-
Total 13F shares
-
44,191,085
-
Share change
-
+3,840,718
-
Total reported value
-
$734,149,889
-
Put/Call ratio
-
23%
-
Price per share
-
$16.62
-
Number of holders
-
121
-
Value change
-
+$63,780,372
-
Number of buys
-
69
-
Number of sells
-
49
Institutional Holders of Kezar Life Sciences Inc - COMMON-STOCK (KZR) as of Q1 2022
As of 31 Mar 2022 Kezar Life Sciences Inc - COMMON-STOCK (KZR) had 121 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 44,191,085 shares of stock of the company.
Largest 10 holders included Bellevue Group AG, Avidity Partners Management LP, BlackRock Inc., FRANKLIN RESOURCES INC, Point72 Asset Management, L.P., STATE STREET CORP, VANGUARD GROUP INC, ADAGE CAPITAL PARTNERS GP, L.L.C., VICTORY CAPITAL MANAGEMENT INC, and Logos Global Management LP.
This table shows 121 institutional shareholders of the security as of 31 Mar 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.